Artivion, Inc. (AORT)
34.73
-1.18
(-3.29%)
USD |
NYSE |
May 06, 16:00
34.72
-0.02
(-0.04%)
Pre-Market: 20:00
Artivion Cash from Investing (Quarterly) : -30.51M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NeuroOne Medical Technologies Corp. | -0.0408M |
| Edwards Lifesciences Corp. | -- |
| Zimmer Biomet Holdings, Inc. | -159.00M |
| PetVivo Holdings, Inc. | 0.0051M |
| Nutriband, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 21.31M |
| Cash from Financing (Quarterly) | 0.68M |
| Free Cash Flow | 0.839M |
| Free Cash Flow Per Share (Quarterly) | -0.1249 |
| Free Cash Flow to Equity (Quarterly) | -2.722M |
| Free Cash Flow to Firm (Quarterly) | -4.145M |
| Free Cash Flow Yield | 0.05% |